U.S. Physical Therapy (NYSE:USPH) CFO Sells $60,104.78 in Stock

Key Points

• CFO Carey Hendrickson sold 698 shares of U.S. Physical Therapy stock for a total of $60,104.78, representing a 2.45% decrease in their ownership position.
• The stock price dropped by 2.2% on the same day, closing at $85.54, with a market cap of $1.30 billion and a PE ratio of 37.35.
• U.S. Physical Therapy recently declared a $0.45 quarterly dividend, with a payout ratio of 78.60%, reflecting an annualized dividend yield of 2.1%.

U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) CFO Carey Hendrickson sold 698 shares of U.S. Physical Therapy stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $86.11, for a total value of $60,104.78. Following the completion of the transaction, the chief financial officer directly owned 27,808 shares in the company, valued at $2,394,546.88. This represents a 2.45% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

U.S. Physical Therapy Stock Down 2.2%

NYSE:USPH traded down $1.8910 on Monday, hitting $85.5390. 118,932 shares of the company's stock traded hands, compared to its average volume of 194,769. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.30. U.S. Physical Therapy, Inc. has a 1 year low of $62.77 and a 1 year high of $101.19. The firm has a 50-day moving average price of $78.42 and a 200-day moving average price of $76.74. The company has a market cap of $1.30 billion, a PE ratio of 37.35, a price-to-earnings-growth ratio of 4.47 and a beta of 1.45.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.10. The business had revenue of $197.34 million during the quarter, compared to analyst estimates of $190.24 million. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%.The firm's revenue was up 18.0% on a year-over-year basis. During the same period in the previous year, the company earned $0.73 EPS. Equities analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 12th. Stockholders of record on Friday, August 22nd will be issued a dividend of $0.45 per share. The ex-dividend date is Friday, August 22nd. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.1%. U.S. Physical Therapy's payout ratio is 78.60%.

Hedge Funds Weigh In On U.S. Physical Therapy

Institutional investors and hedge funds have recently bought and sold shares of the business. Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in U.S. Physical Therapy by 952.4% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 442 shares of the company's stock valued at $32,000 after buying an additional 400 shares during the period. Parallel Advisors LLC lifted its stake in U.S. Physical Therapy by 90.6% in the second quarter. Parallel Advisors LLC now owns 448 shares of the company's stock valued at $35,000 after buying an additional 213 shares during the period. Cullen Frost Bankers Inc. lifted its stake in U.S. Physical Therapy by 171.8% in the second quarter. Cullen Frost Bankers Inc. now owns 443 shares of the company's stock valued at $35,000 after buying an additional 280 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new position in U.S. Physical Therapy in the fourth quarter valued at about $39,000. Finally, Assetmark Inc. lifted its stake in U.S. Physical Therapy by 35.7% in the second quarter. Assetmark Inc. now owns 570 shares of the company's stock valued at $45,000 after buying an additional 150 shares during the period.

Wall Street Analyst Weigh In

USPH has been the topic of a number of research reports. Zacks Research upgraded U.S. Physical Therapy to a "hold" rating in a research report on Friday, August 8th. Barrington Research upped their price target on U.S. Physical Therapy from $98.00 to $103.00 and gave the company an "outperform" rating in a research report on Friday, August 8th. Finally, Wall Street Zen upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.